Filtered By:
Specialty: International Medicine & Public Health
Condition: Addiction

This page shows you your search results in order of date.

Order by Relevance | Date

Total 4 results found since Jan 2013.

NIH STTR grant to fast track new class of pain reliever without addiction or toxicity
(Louisiana State University Health Sciences Center) The National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH) has awarded a $1.9 million Fast-Track Small Business Technology Transfer (STTR) grant to South Rampart Pharma. The New Orleans life science company is developing a new class of non-opioid medicines to relieve pain and reduce fever discovered at and licensed from LSU Health New Orleans, its formal collaborating research institution.
Source: EurekAlert! - Medicine and Health - September 25, 2020 Category: International Medicine & Public Health Source Type: news

International Neuromodulation Society announces 14th World Congress
(International Neuromodulation Society) Researchers from 22 countries will present plenary lectures and nearly 400 abstracts top international research in neuromodulation therapies. New lines of inquiry will be presented about potentially aiding stroke recovery, heart failure, depression, paralysis, cognitive or memory issues, addiction, obesity, and anorexia.
Source: EurekAlert! - Medicine and Health - April 15, 2019 Category: International Medicine & Public Health Source Type: news

NIH launches neurological drug development projects
(NIH/National Institute of Neurological Disorders and Stroke) The NIH launched three innovative projects that will focus on development of therapeutics for Fragile X syndrome, nicotine addiction, and age-related macular degeneration. These projects are funded through the NIH Blueprint Neurotherapeutics Network which provides access to a variety of drug development resources.
Source: EurekAlert! - Social and Behavioral Science - July 31, 2013 Category: Global & Universal Source Type: news

Scientists awarded special collaborative grant to develop anti-addiction medication
(Scripps Research Institute) As part of an unprecedented national effort to develop new drugs to treat neurological disorders, scientists from the Florida campus of the Scripps Research Institute have been awarded an innovative grant from the National Institute of Neurological Disorders and Stroke to help people break their addiction to nicotine.
Source: EurekAlert! - Social and Behavioral Science - March 27, 2013 Category: Global & Universal Source Type: news